The development of selective XPO1 inhibitors in the treatment of acute myeloid leukemia.
- Author:
Xing TONG
1
;
Ying ZHANG
2
;
Jia CHEN
2
;
De Pei WU
2
Author Information
- Publication Type:Journal Article
- MeSH: Humans; Antineoplastic Agents/therapeutic use*; Leukemia, Myeloid, Acute/drug therapy*; Cell Line, Tumor
- From: Chinese Journal of Hematology 2023;44(9):788-792
- CountryChina
- Language:Chinese
